Middle East & Africa Traumatic Brain Injury Biomarkers Market Size & Outlook

The traumatic brain injury biomarkers market in Middle East & Africa is expected to reach a projected revenue of US$ 124.4 million by 2033. A compound annual growth rate of 16.9% is expected of Middle East & Africa traumatic brain injury biomarkers market from 2025 to 2033.
Revenue, 2024 (US$M)
$31.7
Forecast, 2033 (US$M)
$124.4
CAGR, 2025 - 2033
16.9%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa traumatic brain injury biomarkers market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

MEA traumatic brain injury biomarkers market highlights

  • The MEA traumatic brain injury biomarkers market generated a revenue of USD 31.7 million in 2024.
  • The market is expected to grow at a CAGR of 16.9% from 2025 to 2033.
  • In terms of segment, protein biomarkers was the largest revenue generating type in 2024.
  • Metabolomic biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.


MEA data book summary

Market revenue in 2024USD 31.7 million
Market revenue in 2033USD 124.4 million
Growth rate16.9% (CAGR from 2025 to 2033)
Largest segmentProtein biomarkers
Fastest growing segmentMetabolomic biomarkers
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationProtein biomarkers, Genetic biomarkers, Metabolomic biomarkers


Other key industry trends

  • In terms of revenue, MEA region accounted for 3.0% of the global traumatic brain injury biomarkers market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,061.0 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Traumatic Brain Injury Biomarkers Market Companies

Name Profile # Employees HQ Website
Brainbox Solutions View profile 1-10 Drouin, Victoria, Australia, Oceania http://brainboxsolutions.com.au
NeuroTrauma Sciences View profile 11-50 Alpharetta, Georgia, United States, North America http://neurotraumasciences.com/
ImmunArray View profile 51-100 Richmond, Virginia, United States, North America http://www.immunarray.com/
Banyan Biomarkers View profile 11-50 Alachua, Florida, United States, North America http://banyanbio.com
Randox Laboratories View profile - - -
QIAGEN N.V. View profile - - -
Quanterix View profile 251-500 Billerica, Massachusetts, United States, North America http://www.quanterix.com
Fujirebio Diagnostics View profile 5001-10000 Malvern, Pennsylvania, United States, North America http://www.fdi.com/
Thermo Fisher Scientific Inc. View profile - - -
Koninklijke Philips N.V. View profile - - -
Abbott View profile - - -
F. Hoffmann-La Roche Ltd. View profile - - -
GE Healthcare View profile 10001+ Chicago, Illinois, United States, North America http://www.gehealthcare.com
Oculogica View profile 1-10 New York, New York, United States, North America http://www.oculogica.com
Abcam PLC View profile 1760 Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX https://www.abcam.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com

Middle East & Africa traumatic brain injury biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to traumatic brain injury biomarkers market will help companies and investors design strategic landscapes.


Protein biomarkers was the largest segment with a revenue share of 62.46% in 2024. Horizon Databook has segmented the Middle East & Africa traumatic brain injury biomarkers market based on protein biomarkers, genetic biomarkers, metabolomic biomarkers covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Middle East & Africa traumatic brain injury biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa traumatic brain injury biomarkers market databook

  • Our clientele includes a mix of traumatic brain injury biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa traumatic brain injury biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa traumatic brain injury biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA traumatic brain injury biomarkers market size, by country, 2021-2033 (US$M)

Middle East & Africa Traumatic Brain Injury Biomarkers Market Outlook Share, 2024 & 2033 (US$M)

MEA traumatic brain injury biomarkers market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online